Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering mucosal RNA interference in vivo.

Yingjie Zhang1, Patricia Cristofaro, Rebecca Silbermann

  • 1Laboratory of Retrovirology, Division of Infectious Diseases, Department of Medicine, Brown Medical School, 55 Claverick Street, Providence, RI 02903, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

Successful Tarlatamab Rechallenge After Recurrent High-Grade Cytokine Release Syndrome in Chromothripsis-Mediated SCLC: A Case Report.

JTO clinical and research reports·2026
Same author

Effect of alendronate on survival and bone properties in Nothobranchius furzeri: insights from a model of accelerated aging.

Experimental gerontology·2026
Same author

Practice Tips From the Updated <i>Helicobacter pylori</i> Treatment Guidelines.

Gastroenterology & hepatology·2026
Same author

Diagnostic Performance of Point-of-Care Immunoassay Measurements of Pancreatic Stone Protein for Sepsis Detection in ICU Patients: A Prospective, Multicenter, Biomarker-Blinded Study.

Critical care medicine·2026
Same author

Management of Refractory Helicobacter pylori Infection.

Gastro hep advances·2026
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles

Researchers show RNA interference can genetically modify mucosal surfaces. Direct application of liposome-complexed small interfering RNA (siRNA) effectively silences genes in the cervicovaginal and rectal mucosa, offering a new gene therapy approach.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Immunology

Background:

  • Mucosal surfaces are critical entry points for pathogens and disease.
  • Gene expression modulation in mucosal tissues presents therapeutic challenges.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) for in vivo gene manipulation of mucosal surfaces.
  • To evaluate the potential of liposome-complexed small interfering RNA (siRNA) for targeted gene silencing in the cervicovaginal and rectal mucosa.

Main Methods:

  • Utilized a murine model to assess direct application of liposome-complexed siRNA.
  • Administered siRNA targeting specific gene products in the cervicovaginal and rectal mucosa.
  • Evaluated gene silencing efficacy by measuring mRNA levels.

Related Experiment Videos

  • Assessed therapeutic effects in a murine model of inflammatory bowel disease by targeting TNF-alpha.

    • Main Results:

    • Single vaginal or rectal administration of siRNA reduced target mRNA levels by up to 90%.
    • Rectal siRNA targeting TNF-alpha conferred mucosal resistance against experimental colitis.
    • Liposomal siRNA formulations were found to be nontoxic and did not induce a nonspecific interferon response.

    Conclusions:

    • Direct application of liposome-complexed siRNA is an effective method for gene-specific silencing in cervicovaginal and rectal mucosa in vivo.
    • This approach offers a safe and efficient means for the genetic engineering of mucosal surfaces.
    • RNAi-mediated gene silencing holds promise for treating mucosal diseases.